217 related articles for article (PubMed ID: 15255421)
21. Risk factors, prevention, and treatment of corticosteroid-induced osteoporosis in adults.
Ruf KM; Johnson NK; Clifford T; Smith KM
Orthopedics; 2008 Aug; 31(8):768-72. PubMed ID: 18714771
[TBL] [Abstract][Full Text] [Related]
22. Use of highly potent bisphosphonates in the treatment of osteoporosis.
McClung M
Curr Osteoporos Rep; 2003 Dec; 1(3):116-22. PubMed ID: 16036074
[TBL] [Abstract][Full Text] [Related]
23. Prevention and treatment of osteoporosis.
Prestwood KM; Raisz LG
Clin Cornerstone; 2002; 4(6):31-41. PubMed ID: 12739329
[TBL] [Abstract][Full Text] [Related]
24. Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
Compston JE
Gut; 1999 Jun; 44(6):780-1. PubMed ID: 10375295
[No Abstract] [Full Text] [Related]
25. Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.
Devogelaer JP; Sambrook P; Reid DM; Goemaere S; Ish-Shalom S; Collette J; Su G; Bucci-Rechtweg C; Papanastasiou P; Reginster JY
Rheumatology (Oxford); 2013 Jun; 52(6):1058-69. PubMed ID: 23365149
[TBL] [Abstract][Full Text] [Related]
26. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial.
Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T
Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic therapy for the treatment and prevention of osteoporosis.
McClung B; McClung M
Nurs Clin North Am; 2001 Sep; 36(3):433-40, viii. PubMed ID: 11532658
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates.
Diez-Perez A
Maturitas; 2002 Aug; 43 Suppl 1():S19-26. PubMed ID: 12361885
[No Abstract] [Full Text] [Related]
29. Prevention and treatment of osteoporosis.
Prestwood KM; Raisz LG
Clin Cornerstone; 2000; 2(6):34-44. PubMed ID: 10938990
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonates for osteoporosis.
Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.
Miller E
Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143
[TBL] [Abstract][Full Text] [Related]
32. Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
Hershman D; Narayanan R
Curr Oncol Rep; 2004 Jul; 6(4):277-84. PubMed ID: 15161581
[TBL] [Abstract][Full Text] [Related]
33. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
[TBL] [Abstract][Full Text] [Related]
34. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
35. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Goldstein MF; Fallon JJ; Harning R
Chest; 1999 Dec; 116(6):1733-49. PubMed ID: 10593801
[TBL] [Abstract][Full Text] [Related]
36. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
Chitre MM; Hayes W
J Manag Care Pharm; 2008 Apr; 14(3):281-90. PubMed ID: 18439050
[TBL] [Abstract][Full Text] [Related]
37. Treating osteoporosis in post-menopausal women: a case approach.
Keller MI
Cleve Clin J Med; 2004 Oct; 71(10):829-37. PubMed ID: 15529489
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
[TBL] [Abstract][Full Text] [Related]
39. Summaries for patients. Drug therapy for osteoporosis.
Ann Intern Med; 2008 May; 148(9):I28. PubMed ID: 18458273
[No Abstract] [Full Text] [Related]
40. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
